🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2025-524580-21-00
Terminated Phase III

A prospective, randomized, double-blind, placebo-controlled, multicentre, dose-finding clinical trial with polymerised mannan-conjugated allergoid Dactylis glomerata/Phleum pratense administered subcutaneously to patients with grass pollen-induced allergic rhinitis or rhinoconjunctivitis.

2025-524580-21-00 · tracked via the Priya Life Science EU tracker
Sponsor
Inmunotek S.L.
Sponsor type
Pharmaceutical company
Therapeutic area
Immune System Diseases
Decision date
29/05/2026
Enrollment target
450
Sites
Germany

Condition studied

Grass pollen induced allergic rhinitis or rhinoconjunctivitis

Investigational medicinal product(s)

Mometason ratiopharm 50 Mikrogramm/Sprühstoß NasenspraySuspensionPlacebo is identical in appearance an condition to the investigational medicinal product.Budes 64 Mikrogramm/Sprühstoß NasenspraySuspensionAllegra Allergietabletten 20 mg TablettenNASACORT 55 Mikrogramm/Dosis NasenspraySuspensionHAL Allergy Prick Test WiesenlieschgrasEMADINE 0.5 mg/mleye dropssolutionEbastin Aristo 10 mg FilmtablettenCetirizin-ratiopharm® bei Allergien FilmtablettenDesloratadin Glenmark 5 mg TablettenFexofenadin Winthrop 180 mg FilmtablettenAVAMYS 27.5 micrograms/spraynasal spray suspensionBilaxten 6 mg/ml AugentropfenLösungHAL Allergy Prick Test KatzenepithelienOlopatadin Micro Labs 1 mg/ml AugentropfenLösungMannan-conjugated allergoid (polymerized) Phleum pratense and Dactylis glomerata parenteral vaccineALK Prick Positiv Kontrolle - Lösung für Haut-PricktestRupatadin AL 10 mg TablettenHAL Allergy Prick Test HundeepithelienHAL Allergy Pricktest 10 mg/ml Pricktestlösung zur PositivkontrolleHAL Allergy Prick Test Alternaria alternataAzelastin COMOD 05 mg/ml AugentropfenHAL Allergy Prick Test Gräserpollen-MischungLevocetirizin-ratiopharm 5 mg FilmtablettenHAL Allergy Prick Test Hausstaubmilbe Dermatophagoides PteronyssinusLivocab® direkt Augentropfen 005 % AugentropfenSuspensionLoratadin-ratiopharm® 10 mg TablettenALK Prick Negativ Kontrolle - Lösung für Haut-PricktestHAL Allergy Pricktest NegativkontrollePricktestlösungAlvesco 160 Mikrogramm DruckgasinhalationLösungFlutica-Teva® 50 Mikrogramm NasenspraySuspension

Eligibility

Age group
18-64 years
Sex
Female, Male

Primary endpoint

Mean daily Combined Symptom and Medication Score (CSMS, as defined in the EAACI position paper by Pfaar et al., 2014) over the peak grass pollen season 2027.

Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2025-524580-21-00 on CTIS ↗ ← All trials in the EU